ARVNArvinas, Inc.
$7.31-21% 1Y
$7.31
$6.8152 weeks$13.83
Is the price fair?
What ARVN's price assumes
Arvinas, Inc. has no trailing P/E on file, so the price is measured against sales instead: 1.72× revenue.
1.72
Price / sales · no trailing P/E on file: measured against sales instead
- Price / book
- 0.97
Price / book · as of 2026-Q2
Details›
- Price / bookas of 2026-Q2
- 0.97
- EV / EBIToperating margin −5.7%: the multiple describes the denominator
- not meaningful
- Market capitalisation65.4 million shares, counted Jul 31, 2026
- $478M
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Biotechnology
The closest names by size in the same industry